News

Brain Tumor Diagnosis Spurs Nomadic Lifestyle A brain tumor diagnosis in 2014 quickly grounded Dace H.’s fast-paced job at a technology start-up. The life change pushed Dace to slow down and focus on the things that mean the most to him — spending time with friends and family, being in nature, and exploring his creativity through writing and photography. From there, he […] May 16, 2023

World Class Hospitals Join DNA Damage Response Consortium to Bring Forward New Treatments for Adults and Children with Brain Cancer Researchers from St. Jude Children’s Research Hospital, NYU, UCSF, and the University of Minnesota join National Brain Tumor Society and Yale-led Initiative   Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced new partners for its DNA Damage Response Consortium. Joining the initiative are world-class experts in adult and pediatric neuro-oncology […] March 28, 2023

New Brain Tumor Clinical Trials: July- December 2022 It can be hard to keep track of new clinical trial opportunities opening across the United States. There are many clinical trials actively enrolling patients, and this report provides a summary of the studies that have recently opened or started for patients with a primary brain tumor*. Follow the hyperlink above to learn more about […] January 20, 2023

Breakthroughs Ahead: Liz Salmi National Brain Tumor Society board member Liz Salmi and her husband Brett have been living with her grade 2 astrocytoma diagnosis for 15 years. We’re so grateful for her service and for allowing us to share her story with our community. Watch Liz’s video and learn how their experiences have led them to champion the […] December 5, 2022

Q&A: A New Treatment Approved for Certain Brain Tumors In late June 2022, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new treatment combination that will now be available as an option for certain brain tumor patients. The approved combination of two oral drugs, called dabrafenib (brand name: Tafinlar) and trametinib (brand name: Mekinist), is for the treatment of advanced tumors […] August 9, 2022